4.5 Article

An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial

期刊

BMJ-BRITISH MEDICAL JOURNAL
卷 349, 期 -, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bmj.g4315

关键词

-

资金

  1. National Institute for Health Research (NIHR)
  2. Care in Leicestershire, Northamptonshire and Rutland (CLAHRC LNR)
  3. NIHR Leicester Respiratory Biomedical Research Unit
  4. CLAHRC East Midlands
  5. University of Leicester Clinical Trials Unit

向作者/读者索取更多资源

Objective To investigate whether an early rehabilitation intervention initiated during acute admission for exacerbations of chronic respiratory disease reduces the risk of readmission over 12 months and ameliorates the negative effects of the episode on physical performance and health status. Design Prospective, randomised controlled trial. Setting An acute cardiorespiratory unit in a teaching hospital and an acute medical unit in an affiliated teaching district general hospital, United Kingdom. Participants 389 patients aged between 45 and 93 who within 48 hours of admission to hospital with an exacerbation of chronic respiratory disease were randomised to an early rehabilitation intervention (n=196) or to usual care (n=193). Main outcome measures The primary outcome was readmission rate at 12 months. Secondary outcomes included number of hospital days, mortality, physical performance, and health status. The primary analysis was by intention to treat, with prespecified per protocol analysis as a secondary outcome. Interventions Participants in the early rehabilitation group received a six week intervention, started within 48 hours of admission. The intervention comprised prescribed, progressive aerobic, resistance, and neuromuscular electrical stimulation training. Patients also received a self management and education package. Results Of the 389 participants, 320 (82%) had a primary diagnosis of chronic obstructive pulmonary disease. 233 (60%) were readmitted at least once in the following year (62% in the intervention group and 58% in the control group). No significant difference between groups was found (hazard ratio 1.1, 95% confidence interval 0.86 to 1.43, P=0.4). An increase in mortality was seen in the intervention group at one year (odds ratio 1.74, 95% confidence interval 1.05 to 2.88, P=0.03). Significant recovery in physical performance and health status was seen after discharge in both groups, with no significant difference between groups at one year. Conclusion Early rehabilitation during hospital admission for chronic respiratory disease did not reduce the risk of subsequent readmission or enhance recovery of physical function following the event over 12 months. Mortality at 12 months was higher in the intervention group. The results suggest that beyond current standard physiotherapy practice, progressive exercise rehabilitation should not be started during the early stages of the acute illness.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Respiratory System

High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial

Claudia Crimi, Alberto Noto, Fabiana Madotto, Mariachiara Ippolito, Santi Nolasco, Raffaele Campisi, Stefano De Vuono, Giuseppe Fiorentino, Ioannis Pantazopoulos, Athanasios Chalkias, Alessandro Libra, Alessio Mattei, Raffaele Scala, Enrico M. Clini, Begum Ergan, Manel Lujan, Joao Carlos Winck, Antonino Giarratano, Annalisa Carlucci, Cesare Gregoretti, Paolo Groff, Andrea Cortegiani

Summary: Among patients with COVID-19 pneumonia and mild hypoxaemia, the use of HFNO did not significantly reduce the likelihood of escalation of respiratory support.

THORAX (2023)

Letter Respiratory System

Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia

A. Verduri, J. Hewitt, B. Carter, R. Tonelli, E. Clini, B. Beghe

PULMONOLOGY (2023)

Article Critical Care Medicine

Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post-COVID-19 Study

Iain Stewart, Joseph Jacob, Peter M. George, Philip L. Molyneaux, Joanna C. Porter, Richard J. Allen, Shahab Aslani, J. Kenneth Baillie, Shaney L. Barratt, Paul Beirne, Stephen M. Bianchi, John F. Blaikley, James D. Chalmers, Rachel C. Chambers, Nazia Chadhuri, Christopher Coleman, Guilhem Collier, Emma K. Denneny, Annemarie Docherty, Omer Elneima, Rachael A. Evans, Laura Fabbri, Michael A. Gibbons, Fergus Gleeson, Bibek Gooptu, Neil J. Greening, Beatriz Guillen Guio, Ian P. Hall, Neil A. Hanley, Victoria Harris, Ewen M. Harrison, Melissa Heightman, Toby E. Hillman, Alex Horsley, Linzy Houchen-Wolloff, Ian Jarrold, Simon R. Johnson, Mark G. Jones, Fasihul Khan, Rod Lawson, Olivia Leavy, Nazir Lone, Michael Marks, Hamish McAuley, Puja Mehta, Dhruv Parekh, Karen Piper Hanley, Manuela Plate, John Pearl, Krisnah Poinasamy, Jennifer K. Quint, Betty Raman, Matthew Richardson, Pilar Rivera-Ortega, Laura Saunders, Ruth Saunders, Malcolm G. Semple, Marco Sereno, Aarti Shikotra, A. John Simpson, Amisha Singapuri, David J. F. Smith, Mark Spears, Lisa G. Spencer, Stefan Stanel, David R. Thickett, A. A. Roger Thompson, Mathew Thorpe, Simon L. F. Walsh, Samantha Walker, Nicholas David Weatherley, Mark E. Weeks, Jim M. Wild, Dan G. Wootton, Chris E. Brightling, Ling-Pei Ho, Louise Wain, Gisli R. Jenkins

Summary: This study analyzed the data from the UK Interstitial Lung Disease Consortium (UKILD) post-COVID-19 study to estimate the prevalence of residual lung abnormalities in hospitalized COVID-19 patients. The results showed that approximately 11% of recovered COVID-19 patients had residual lung abnormalities, highlighting the need for long-term monitoring.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Medicine, Research & Experimental

The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium

Enya Daynes, Molly Baldwin, Neil J. Greening, Thomas Yates, Nicolette C. Bishop, George Mills, Matthew Roberts, Malik Hamrouni, Tatiana Plekhanova, Ioannis Vogiatzis, Carlos Echevarria, Rashmita Nathu, Hamish J. C. McAuley, Lorna Latimer, Jennifer Glennie, Francesca Chambers, Ruth Penfold, Emily Hume, Dimitrios Magaritis, Charikleia Alexiou, Sebastian Potthoff, Mitchell James Hogg, Catherine Haighton, Bethany Nichol, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Claire M. Nolan, Charlotte Bolton, Linzy Houchen-Wolloff, Ewen M. Harrison, Nazir Lone, Jennifer Quint, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Ramen, Louise V. Wain, Christopher Brightling, William D. -C. Man, Rachael Evans, Sally J. Singh

Summary: This study aims to compare the effectiveness of rehabilitation interventions with usual care for COVID-19 patients. The results will be published in appropriate journals. Although rehabilitation interventions show promise in improving function and symptoms, there is limited evidence and more research is needed for validation.

TRIALS (2023)

Correction Medicine, Research & Experimental

The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium (vol 24, 61, 2023)

Enya Daynes, Molly Baldwin, Neil J. Greening, Thomas Yates, Nicolette C. Bishop, George Mills, Matthew Roberts, Malik Hamrouni, Tatiana Plekhanova, Ioannis Vogiatzis, Carlos Echevarria, Rashmita Nathu, Hamish J. C. McAuley, Lorna Latimer, Jennifer Glennie, Francesca Chambers, Ruth Penfold, Emily Hume, Dimitrios Megaritis, Charikleia Alexiou, Sebastian Potthof, Mitchell James Hogg, Catherine Haighton, Bethany Nichol, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Amisha Singapuri, Marco Sereno, Ruth M. Saunders, Victoria C. Harris, Claire M. Nolan, Charlotte Bolton, Linzy Houchen-Wolloff, Ewen M. Harrison, Nazir Lone, Jennifer Quint, James D. Chalmers, Ling-Pei Ho, Alex Horsley, Michael Marks, Krisnah Poinasamy, Betty Ramen, Louise V. Wain, Christopher Brightling, William D. -C. Man, Rachael Evans, Sally J. Singh

TRIALS (2023)

Article Surgery

Case report: Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula

Francesco Mattioli, Edoardo Serafini, Alessandro Andreani, Gaia Cappiello, Daniele Marchioni, Massimo Pinelli, Roberto Tonelli, Enrico Clini, Alessandro Marchioni

Summary: This paper presents a case report of bronchoscopic fistula closure using autologous fascia lata graft placement in a patient with pulmonary squamous cell carcinoma. The esophageal stent was retained due to the high risk associated with its removal. After 7 months of treatment, no recurrence of tracheoesophageal fistula was observed.

FRONTIERS IN SURGERY (2023)

Review Geriatrics & Gerontology

Frailty Prevalence and Association with Clinical Outcomes in Interstitial Lung Disease, Asthma, and Pleural Disease

Alessia Verduri, Ben Carter, Ceara Rice, James Laraman, Eleanor Barton, Enrico Clini, Nick A. Maskell, Jonathan Hewitt

Summary: This article investigates the prevalence and impact of frailty in adult patients with interstitial lung disease (ILD), asthma, and pleural disease. The prevalence of frailty in asthma was found to be 9.5%, and in ILD, it was 48%. The study also found that frail ILD patients have an increased risk of long-term mortality.

GERIATRICS (2023)

Review Medicine, General & Internal

Frailty and its influence on mortality and morbidity in COPD: A Systematic Review and Meta-Analysis

Alessia Verduri, Ben Carter, James Laraman, Ceara Rice, Enrico Clini, Nick Anthony Maskell, Jonathan Hewitt

Summary: Frailty increases vulnerability to adverse outcomes, and it is common in patients with COPD. This study found a significant association between frailty and higher mortality risk in COPD patients. Frailty was also positively associated with hospital readmissions and all cause hospitalizations.

INTERNAL AND EMERGENCY MEDICINE (2023)

Review Biochemistry & Molecular Biology

Molecular Biology and Therapeutic Targets of Primitive Tracheal Tumors: Focus on Tumors Derived by Salivary Glands and Squamous Cell Carcinoma

Alessandro Marchioni, Roberto Tonelli, Anna Valeria Samarelli, Gaia Francesca Cappiello, Alessandro Andreani, Luca Tabbi, Francesco Livrieri, Annamaria Bosi, Ottavia Nori, Francesco Mattioli, Giulia Bruzzi, Daniele Marchioni, Enrico Clini

Summary: Primary tracheal tumors are rare, accounting for approximately 0.1-0.4% of malignant diseases. Squamous cell carcinoma and adenoid cystic carcinoma are the most common types. While surgery and radiotherapy are often effective treatments, unresectable, recurrent, and metastatic tumors may require systemic therapy. Targeted therapy against driver mutations has shown promise as an alternative to chemotherapy for more advanced cases. This review highlights the current understanding of the molecular biology and preliminary data on targeted treatments for primary tracheal tumors, focusing on salivary-gland-derived cancers and squamous cell carcinoma.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Letter Critical Care Medicine

Long COVID research: an update from the PHOSP-COVID Scientific Summit

Christopher E. Brightling, Rachael A. Evans, Amisha Singapuri, Nikki Smith, Louise Wain

LANCET RESPIRATORY MEDICINE (2023)

Article Critical Care Medicine

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

Betty Raman, Celeste McCracken, Mark P. Cassar, Alastair J. Moss, Lucy Finnigan, Azlan Helmy A. Samat, Godwin Ogbole, Elizabeth M. Tunnicliffe, Fidel Alfaro-Almagro, Ricarda Menke, Cheng Xie, Fergus Gleeson, Elena Lukaschuk, Hanan Lamlum, Kevin McGlynn, Iulia A. Popescu, Zeena-Britt Sanders, Laura Saunders, Stefan K. Piechnik, Vanessa M. Ferreira, Chrysovalantou Nikolaidou, Najib M. Rahman, Ling-Pei Ho, Victoria C. Harris, Aarti Shikotra, Amisha Singapuri, Paul Pfeffer, Charlotte Manisty, Onn Min Kon, Mark Beggs, Declan P. O'Regan, Jonathan Fuld, Jonathan R. Weir-McCall, Dhruv Parekh, Rick Steeds, Krisnah Poinasamy, Dan J. Cuthbertson, Graham J. Kemp, Malcolm G. Semple, Alexander Horsley, Christopher A. Miller, Caitlin O'Brien, Ajay M. Shah, Amedeo Chiribiri, Olivia C. Leavy, Matthew Richardson, Omer Elneima, Hamish J. C. McAuley, Marco Sereno, Ruth M. Saunders, Linzy Houchen-Wolloff, Neil J. Greening, Charlotte E. Bolton, Jeremy S. Brown, Gourab Choudhury, Nawar Diar Bakerly, Nicholas Easom, Carlos Echevarria, Michael Marks, John R. Hurst, Mark G. Jones, Daniel G. Wootton, Trudie Chalder, Melanie J. Davies, Anthony De Soyza, John R. Geddes, William Greenhalf, Luke S. Howard, Joseph Jacob, William D-C Man, Peter J. M. Openshaw, Joanna C. Porter, Matthew J. Rowland, Janet T. Scott, Sally J. Singh, David C. Thomas, Mark Toshner, Keir Lewis, Liam G. Heaney, Ewen M. Harrison, Steven Kerr, Annemarie B. Docherty, Nazir I. Lone, Jennifer K. Quint, Aziz Sheikh, Bang Zheng, Gisli Jenkins, Eleanor F. Cox, Susan Francis, Mark Halling-Brown, James D. Chalmers, John P. Greenwood, Sven Plein, Paul J. C. Hughes, A. A. Roger Thompson, Sarah Rowland-Jones, James M. Wild, Matthew Kelly, Thomas A. Treibel, Steven Bandula, Raminder Aul, Karla Miller, Peter Jezzard, Stephen Smith, Thomas E. Nichols, Gerry P. McCann, Rachael A. Evans, Louise V. Wain, Christopher E. Brightling, Stefan Neubauer

Summary: The multiorgan impact of moderate to severe coronavirus infections in the post-acute phase is still poorly understood. This study aimed to evaluate the excess burden of multiorgan abnormalities after hospitalisation with COVID-19, evaluate their determinants, and explore associations with patient-related outcome measures. The findings highlight the need for proactive multidisciplinary care pathways with imaging playing a potential role in guiding surveillance and treatment strategies.

LANCET RESPIRATORY MEDICINE (2023)

Article Infectious Diseases

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients

Simone Campani, Marta Talamonti, Lorenzo Dall'Ara, Irene Coloretti, Ilenia Gatto, Emanuela Biagioni, Martina Tosi, Marianna Meschiari, Roberto Tonelli, Enrico Clini, Andrea Cossarizza, Giovanni Guaraldi, Cristina Mussini, Mario Sarti, Tommaso Trenti, Massimo Girardis

Summary: The study aimed to evaluate the association of PCT and CRP with secondary infections acquired during ICU stay in critically ill COVID-19 patients. The results showed that PCT and CRP values were associated with infections acquired during the ICU stay and can be used to support the diagnosis of these infections.

ANTIBIOTICS-BASEL (2023)

Article Medicine, General & Internal

COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren's Syndrome

Alessia Laneri, Stefania Cerri, Giovanni Della Casa, Antonio Moretti, Andreina Manfredi, Marco Sebastiani, Enrico Clini, Carlo Salvarani

Summary: This case report highlights the challenges in differentiating COVID-19 sequelae with fibrotic features from preexisting pSS-ILD. A wait and see approach was taken, and the patient's clinical symptoms and radiologic manifestations eventually resolved.

CASE REPORTS IN MEDICINE (2023)

Article Virology

Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study

Valeria Caciagli, Irene Coloretti, Marta Talamonti, Carlotta Farinelli, Ilenia Gatto, Emanuela Biagioni, Mario Sarti, Erica Franceschini, Marianna Meschiari, Cristina Mussini, Roberto Tonelli, Enrico Clini, Massimo Girardis, Stefano Busani

Summary: CMV reactivation is common in critically ill COVID-19 patients with prior CAPA diagnosis. Basal immunosuppression before COVID-19 appears to be the primary independent variable affecting CMV reactivation in patients with CAPA. Furthermore, the association of CAPA+CMV versus CAPA alone appears to impact ICU length of stay and secondary bacterial infections but not mortality.

VIRUSES-BASEL (2023)

Article Critical Care Medicine

Physiological effects of lung-protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study

Roberto Tonelli, Salvatore Grasso, Andrea Cortegiani, Lorenzo Ball, Ivana Castaniere, Luca Tabbi, Riccardo Fantini, Dario Andrisani, Filippo Gozzi, Antonio Moretti, Giulia Bruzzi, Linda Manicardi, Stefania Cerri, Anna Valeria Samarelli, Giulia Raineri, Francesco Murgolo, Andrea Carzoli, Rossella Di Mussi, Stefano Busani, Raffaella Rizzoni, Giacomo Grasselli, Enrico Clini, Alessandro Marchioni

Summary: This study aims to investigate the physiological effects of lung-protective ventilation in patients with AE-ILD-UIP and compare it with primary ARDS. The findings indicate that, unlike patients with primary ARDS, adjusting positive end-expiratory pressure to achieve a positive transpulmonary pressure significantly worsened lung mechanics in mechanically ventilated AE-ILD-UIP patients.

CRITICAL CARE (2023)

暂无数据